Attorney General Takes Next Step in Opioid Fight

Attorneys general of 41 states, including NY, have subpoenaed opioid manufacturers and distributors in an investigation into whether the companies are responsible for addiction among users of the drugs.

West Virginia and Kentucky attorney generals Patrick Morrisey and Andy Beshear announced the coalition in press conference at Marshall University Monday afternoon.

This is an expansion on an investigation that was announced in June, which only focused on the drug-maker Purdue Pharma.

The group also demanded documents from distribution companies AmerisourceBergen, Cardinal Health and McKesson. “There’s no doubt that there simply are too many prescriptions for too many opioids in America right now”. Numbers that Schneiderman says are very powerful.

Nationwide and in SC, opioids – prescription and illicit – are the main driver of drug overdose deaths.

Across the US, over 64,000 people have died from an opioid drug overdose in 2016.

Minot and all North Dakota residents know the havoc that opioid abuse is causing for our communities, for healthcare providers and with law enforcement. “It’s a national emergency”.

Health officials are blaming Fentanyl, an opioid, for the increase.

Both manufacturers and distributors are being targeted. None of these states is involved in the broader multistate investigation.

Obtaining an agreement with Amphastar Pharmaceuticals, Inc.to cut and cap the price of naloxone for all agencies in New York State, reducing the price of naloxone by almost 20 percent. A spokesman for Allergan said the company’s two opioid products account for less than 0.08% of all those prescribed in the U.S.in 2016.

Ford said he plans to present a joint resolution, between city and county, supporting litigation at the October 3 council meeting.

“The opioid epidemic has had a devastating impact on millions of families across the country, and Colorado has certainly not been immune to this crisis”, Coffman said in a statement.

“Part of our job as attorneys general is to … ensure that where industry reform is possible is something we’re going to hold out for”, Jepsen said. “This is a multifaceted public health challenge, and we look forward to working collaboratively with government entities to be part of the solution”. Teva is an Israeli multinational, while Cephalon is based in Frazer, also in suburban Philadelphia.